Mind Medicine (MindMed) Inc. (MNMD) Social Stream
Mind Medicine (MindMed) Inc (MNMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Mind Medicine (MindMed) Inc.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-30 | 2 | $10 | $6 | $8 | $1.07 | 647.66% |
MNMD Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 2 | 0 | 0 | 0 | 0 | 2 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MNMD has a higher upside potential (average analyst target price relative to current price) than 97.56% of all US stocks.
- Mind Medicine (MindMed) Inc's number of analysts covering the stock is greater than 4.69% of Healthcare stocks.
- MNMD has a greater average analyst price target than 12.13% of Healthcare stocks.
- In terms of how Mind Medicine (MindMed) Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than 33.83% of that group.
Stocks similar to Mind Medicine (MindMed) Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CDXC, VIVO, and TRIB.
Make investment decisions regarding MNMD using the data that counts. Try POWR Ratings for free.